Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's disease

Inflammatory Bowel Diseases

Volumn 18, Issue 9, 2012, Pages 1743-1748

  Murdoch, Travis B ^a   Xu, Wei ^a   Stempak, Joanne M ^a   Landers, Carol ^a   Targan, Stephan R ^a   Rotter, Jerome I ^a   Silverberg, Mark S ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

ASCA; biomarkers; genetics; inflammatory bowel disease; NOD2

Indexed keywords

FLAGELLIN ANTIBODY; I2 ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; OUTER MEMBRANE PROTEIN OMPC ANTIBODY; PATTERN RECOGNITION RECEPTOR; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ALLELE; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; ATG16L1 GENE; AUTOPHAGY; CROHN DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; IL 12B GENE; INTERLEUKIN 23 RECEPTOR GENE; IRGM GENE; MAJOR CLINICAL STUDY; MALE; NOD2 GENE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STAT3 GENE; TOLL LIKE RECEPTOR 5 GENE;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTIBODIES, FUNGAL; ANTIGENS, BACTERIAL; AUTOPHAGY; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CROHN DISEASE; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GTP-BINDING PROTEINS; HUMANS; INTERLEUKIN-12 SUBUNIT P40; MALE; MIDDLE AGED; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN; RECEPTORS, PATTERN RECOGNITION; SACCHAROMYCES CEREVISIAE; STAT3 TRANSCRIPTION FACTOR; TERTIARY CARE CENTERS; TOLL-LIKE RECEPTOR 5; YOUNG ADULT;

EID: 84865046984     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.22884     Document Type: Article

References (41)

1. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001; 411: 599-603.
2. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001; 411: 603-606.
3. Cooney R, Baker J, Brain O, et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med. 2010; 16: 90-97.
4. Travassos L, Carneiro L, Ramjeet M, et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol. 2009; 11: 55-62.
5. Parkes M, Barrett JC, Prescott NJ, et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet. 2007; 39: 830-832.
6. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet. 2007; 39: 596-604.
7. Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000; 13: 715-725.
8. McGovern D, Powrie F,. The IL23 axis plays a key role in the pathogenesis of IBD. Gut. 2007; 56: 1333-1336.
9. Ahern PP, Izcue A, Maloy KJ, et al. The interleukin-23 axis in intestinal inflammation. Immunol Rev. 2008; 226: 147-159.
10. Elson CO, Cong Y, Weaver CT, et al. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology. 2007; 132: 2359-2370.
11. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006; 314: 1461-1463.
12. McGovern DP, Rotter JI, Mei L, et al. Genetic epistasis of IL23/IL17 pathway genes in Crohn's disease. Inflamm Bowel Dis. 2009; 15: 883-889.
13. Taylor KD, Targan SR, Mei L, et al. IL23R haplotypes provide a large population attributable risk for Crohn's disease. Inflamm Bowel Dis. 2008; 14: 1185-1191.
14. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet. 2007; 39: 207-211.
15. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008; 40: 955-962.
16. Dubinsky MC, Wang D, Picornell Y, et al. IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease. Inflamm Bowel Dis. 2007; 13: 511-515.
17. Cho JH,. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol. 2008; 8: 458-66.
18. Podolsky DK,. Inflammatory bowel disease. N Engl J Med. 2002; 347: 417-429.
19. Devlin SM, Yang H, Ippoliti A, et al. NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives. Gastroenterology. 2007; 132: 576-586.
20. Standaert-Vitse A, Jouault T, Vandewalle P, et al. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. Gastroenterology. 2006; 130: 1764-1775.
21. Landers CJ, Cohavy O, Misra R, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology. 2002; 123: 689-699.
22. Papp M, Altorjay I, Norman GL, et al. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients. Inflamm Bowel Dis. 2007; 13: 984-992.
23. Marrakchi R, Bougatef K, Moussa A, et al. 3020insC insertion in NOD2/CARD15 gene, a prevalent variant associated with anti-Saccharomyces cerevisiae antibodies and ileal location of Crohn's disease in Tunisian population. Inflamm Res. 2009; 58: 218-223.
24. Dassopoulos T, Frangakis C, Cruz-Correa M, et al. Antibodies to Saccharomyces cerevisiae in Crohn's disease: higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease. Inflamm Bowel Dis. 2007; 13: 143-151.
25. Henckaerts L, Pierik M, Joossens M, et al. Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease. Gut. 2007; 56: 1536.
26. Gewirtz AT, Vijay-Kumar M, Brant SR, et al. Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease. Am J Physiol Gastrointest Liver Physiol. 2006; 290: G1157-1163.
27. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005; 19 (Suppl A): 5-36.
28. Shen R, Fan J-B, Campbell D, et al. High-throughput SNP genotyping on universal bead arrays. Mutat Res. 2005; 573: 70-82.
29. Landers CJ, Cohavy O, Misra R, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology. 2002; 123: 689-699.
30. Hawn TR, Verbon A, Lettinga KD, et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J Exp Med. 2003; 198: 1563-1572.
31. Annese V, Lombardi G, Perri F, et al. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease€"an IG-IBD study. Am J Gastroenterol. 2005; 100: 84-92.
32. van der Graaf CAA, Netea MG, Franke B, et al. Nucleotide oligomerization domain 2 (Nod2) is not involved in the pattern recognition of Candida albicans. Clin Vaccine Immunol. 2006; 13: 423-425.
33. Buhner S, Buning C, Genschel J, et al. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation? Gut. 2006; 55: 342-347.
34. Harrer M, Reinisch W, Dejaco C, et al. Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease? Eur J Gastroenterol Hepatol. 2003; 15: 1281-1285.
35. Vermeire S, Peeters M, Vlietinck R, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families. Inflamm Bowel Dis. 2001; 7: 8-15.
36. Means TK, Hayashi F, Smith KD, et al. The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells. J Immunol. 2003; 170: 5165-5175.
37. Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 2010; 328: 228-231.
38. McGeachy MJ, Cua DJ,. Th17 cell differentiation: the long and winding road. Immunity. 2008; 28: 445-453.
39. Janeway CA, Medzhitov R,. Innate immune recognition. Annu Rev Immunol. 2002; 20: 197-216.
40. Uhlig HH, McKenzie BS, Hue S, et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity. 2006; 25: 309-318.
41. Buonocore S, Ahern PP, Uhlig HH, et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature. 2010; 464: 1371-1375.